Literature DB >> 24119324

Acceptability of oral and topical HIV chemoprophylaxis in India: implications for at-risk women and men who have sex with men.

Nomita Chandhiok1, Smita N Joshi2, Raman Gangakhedkar3.   

Abstract

With reducing HIV prevalence, India has made gains in containing the epidemic. Yet, unprotected sex and commercial sex work, unprotected anal sex between men and needle sharing among intravenous drug users continue to drive the epidemic. Development of effective, safe and acceptable topical (microbicides) and oral (pre-exposure prophylaxis (PrEP)) chemoprophylaxis could augment the already available tools for HIV prevention. This paper reviews the acceptability of topical microbicides and oral PrEP, in the context of the nature of the HIV epidemic, the sociocultural norms and the acceptability data obtained from studies carried out in India. Overall, men and women have a positive attitude towards the concept and use of microbicide products. Self-perceptions of HIV risk, product attributes, ease and convenience of use during sex, gender norms, the sociocultural context and the potential for undisclosed use were important factors influencing acceptability. A multipurpose product that would simultaneously address women's contraceptive and disease prevention needs would be devoid of the stigma attached to an anti-HIV product and may be more acceptable. Limited information on the acceptability of oral PrEP amongst high-risk groups merits further research, including carrying out demonstration projects for program introduction.

Entities:  

Year:  2014        PMID: 24119324     DOI: 10.1071/SH13067

Source DB:  PubMed          Journal:  Sex Health        ISSN: 1448-5028            Impact factor:   2.706


  5 in total

1.  Perspectives on HIV prevention among urban black women: a potential role for HIV pre-exposure prophylaxis.

Authors:  Charlene A Flash; Valerie E Stone; Jennifer A Mitty; Matthew J Mimiaga; Kathryn T Hall; Douglas Krakower; Kenneth H Mayer
Journal:  AIDS Patient Care STDS       Date:  2014-12       Impact factor: 5.078

2.  Preference of Oral Tenofovir Disoproxil Fumarate/Emtricitabine Versus Rectal Tenofovir Reduced-Glycerin 1% Gel Regimens for HIV Prevention Among Cisgender Men and Transgender Women Who Engage in Receptive Anal Intercourse with Men.

Authors:  Alex Carballo-Diéguez; Rebecca Giguere; Curtis Dolezal; Cheng-Shiun Leu; Iván C Balán; William Brown; Christine Rael; Barbra A Richardson; Jeanna M Piper; Linda-Gail Bekker; Suwat Chariyalertsak; Anupong Chitwarakorn; Pedro Gonzales; Timothy H Holtz; Albert Liu; Kenneth H Mayer; Carmen D Zorrilla; Javier R Lama; Ian McGowan; Ross D Cranston
Journal:  AIDS Behav       Date:  2017-12

3.  Awareness of and willingness to use pre-exposure prophylaxis (PrEP) among people who inject drugs and men who have sex with men in India: Results from a multi-city cross-sectional survey.

Authors:  Ashwin Belludi; Allison M McFall; Sunil Suhas Solomon; David D Celentano; Shruti H Mehta; A K Srikrishnan; M Suresh Kumar; Suniti Solomon; Gregory M Lucas
Journal:  PLoS One       Date:  2021-02-25       Impact factor: 3.240

4.  PrEP implementation in the Asia-Pacific region: opportunities, implementation and barriers.

Authors:  Iryna Zablotska; Andrew E Grulich; Nittaya Phanuphak; Tarandeep Anand; Surang Janyam; Midnight Poonkasetwattana; Rachel Baggaley; Frits van Griensven; Ying-Ru Lo
Journal:  J Int AIDS Soc       Date:  2016-10-18       Impact factor: 5.396

5.  Antiretroviral pre-exposure prophylaxis: A new opportunity to slow HIV spread in India.

Authors:  Kenneth H Mayer; Nomita Chandhiok; Beena Thomas
Journal:  Indian J Med Res       Date:  2016-02       Impact factor: 2.375

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.